Inventor
ROBERT EVANS
Inventor
US
Overview
Patents· 8 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds16%
C12NMicroorganisms or enzymes16%
C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture16%
C12YEnzymes16%
A61KPreparations for medical, dental or toiletry purposes6%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
C07KPeptides6%
A61BDiagnosis3%
B60FVehicles for use both on rail and on road3%
B61CLocomotives3%
PatentTitleYear
12,371,506Subcutaneous administration of anti-CD38 antibodies202511,820,406Magnetic traction assist for railcar mover202311,293,041Neurotransmitters and methods of making the same202211,261,469Neurotransmitters and methods of making the same202211,242,546Neurotransmitters and methods of making the same202211,242,547Neurotransmitters and methods of making the same202211,214,621Methods for treating chronic sinusitis with nasal polyps by administering an IL-4R antagonist202211,193,151Neurotransmitters and methods of making the same2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2022Patents assigned to PURISSIMA INC (5)· patent assignee history
2021–2025Based in US· patent location history
2022Patents assigned to REGENERAN PHARMACEUTICALS INC (1)· patent assignee history
2025Patents assigned to DAHL MARTIN (1)· patent assignee history
2025Patents assigned to EVANS ROBERT (1)· patent assignee history
2025Patents assigned to FEDYK ERIC (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| PURISSIMA INC | 5 | 2021–2022 |
| DAHL MARTIN | 1 | 2025 |
| EVANS ROBERTself | 1 | 2025 |
| FEDYK ERIC | 1 | 2025 |
| REGENERAN PHARMACEUTICALS INC | 1 | 2022 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 8 | 2021–2025 |